Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
50,377,944
-
Share change
-
-1,531,133
-
Total reported value
-
$8,762,290,786
-
Put/Call ratio
-
70%
-
Price per share
-
$173.95
-
Number of holders
-
378
-
Value change
-
-$264,447,068
-
Number of buys
-
192
-
Number of sells
-
186
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2015
As of 30 Jun 2015,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
378 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,377,944 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, SCOPIA CAPITAL MANAGEMENT LP, DEUTSCHE BANK AG\, STATE STREET CORP, IRIDIAN ASSET MANAGEMENT LLC/CT, BlackRock Institutional Trust Company, N.A., Palo Alto Investors, LLC, and BlackRock Advisors LLC.
This page lists
379
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.